The Illinois Wellness Insider
SEE OTHER BRANDS

Informing on health and wellness news in Illinois

The Illinois Wellness Insider: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.

Press releases published on April 15, 2025

The Ripple Effect Arts Leverages Social Media to Showcase the Benefits of Magnesium Spray, Driving 200% Audience Growth

The Ripple Effect Arts Leverages Social Media to Showcase the Benefits of Magnesium Spray, Driving 200% Audience Growth

The Ripple Effect Arts, a leader in the wellness industry, is making waves online by utilizing social media to highlight the benefits of wellness products. KANKAKEE, IL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Especially its popular Magic …

Flottweg Features Separation Solutions for Pharmaceutical, Chemical & Fermentation Processes

Flottweg Features Separation Solutions for Pharmaceutical, Chemical & Fermentation Processes

Visit Flottweg at the Powder …

Top communication expert warns professionals overly relying on AI-generated content

Top communication expert warns professionals overly relying on AI-generated content

A top communications expert discusses the personal branding risk professionals face when using AI-generated content at work. CHICAGO, IL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Stacey Hanke, a Fortune 500 top communications expert, recently …

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or …

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in …

Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis

Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis

Photo Courtesy of Diet By Tam BEIRUT, Lebanon, April 15, 2025 (GLOBE NEWSWIRE) -- Diet by Tam, a health and wellness company based in Beirut, has announced the expansion of its functional supplement range with the introduction of five new products. The …

Theratechnologies Provides Update on Sale Process

Theratechnologies Provides Update on Sale Process

MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current …

Theratechnologies fait le point sur le processus de vente

Theratechnologies fait le point sur le processus de vente

MONTRÉAL, 15 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui qu’après un examen attentif des circonstances …

Vitalgen's Cutting-Edge Gene Editing and Delivery Platforms to be Featured at AACR Annual Meeting 2025

Vitalgen's Cutting-Edge Gene Editing and Delivery Platforms to be Featured at AACR Annual Meeting 2025

Collaborative research with Grit Biotechnology showcases Vitalgen's proprietary platform and delivery systems in oncology applications CHICAGO, IL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Vitalgen BioPharma Co., Ltd. ("Vitalgen"), a pioneer …

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the first patient in China has been dosed in the …

Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care

Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care

CEDAR PARK, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Ascension Seton is deepening its commitment to patient-centered care in Central Texas by acquiring full ownership of Cedar Park Medical Center. This transition marks a significant step in Ascension …

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025

Reports expansion of CompuFlo® Epidural System across additional  pain management clinics and ambulatory surgery centers following  Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025 (GLOBE NEWSWIRE) --  Milestone Scientific …

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery

Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …

Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling

Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling

Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling CHICAGO, IL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Dr. Sam Speron, a board-certified plastic surgeon and founder of Dr. Speron's Natural …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service